Australasian Diabetes Congress 2024

ADS Invited Speaker

Associate Professor Drew is an NHMRC L1 Investigator Fellow and prior NHF Future Leader Fellow. He is head of the Molecular Metabolism and Ageing Laboratory at the Baker Heart & Diabetes Institute, where he also leads the Obesity & Lipid Program. He leads a team of >15 researchers that engages in cutting edge technologies including systems genetics and CRISPR, to identify novel therapies and diagnostics for cardiometabolic disease. His lab has secured >$10M in competitive funding, with his work being published in many leading journals including Nature, Cell Metabolism, Science Transl Med, Nature Commun, Nature Metab, Nature CVR and more.